首页> 美国卫生研究院文献>Molecular Oncology >Exosomal microRNAs as tumor markers in epithelial ovarian cancer
【2h】

Exosomal microRNAs as tumor markers in epithelial ovarian cancer

机译:外泌体微RNAs作为上皮性卵巢癌的肿瘤标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Specific microRNAs (miRNAs) are packaged in exosomes that regulate processes in tumor development and progression. The current study focuses on the influence of exosomal miRNAs in the pathogenesis of epithelial ovarian cancer (EOC). MiRNA profiles were determined in exosomes from plasma of 106 EOC patients, eight ovarian cystadenoma patients, and 29 healthy women by TaqMan real‐time PCR‐based miRNA array cards containing 48 different miRNAs. In cell culture experiments, the impact of miR‐200b and miR‐320 was determined on proliferation and apoptosis of ovarian cancer cell lines. We report that miR‐21 (P = 0.0001), miR‐100 (P = 0.034), miR‐200b (P = 0.008), and miR‐320 (P = 0.034) are significantly enriched, whereas miR‐16 (P = 0.009), miR‐93 (P = 0.014), miR‐126 (P = 0.012), and miR‐223 (P = 0.029) are underrepresented in exosomes from plasma of EOC patients as compared to those of healthy women. The levels of exosomal miR‐23a (P = 0.009, 0.008) and miR‐92a (P = 009, 0.034) were lower in ovarian cystadenoma patients than in EOC patients and healthy women, respectively. The exosomal levels of miR‐200b correlated with the tumor marker CA125 (P = 0.002) and patient overall survival (P = 0.019). MiR‐200b influenced cell proliferation (P = 0.0001) and apoptosis (P < 0.008). Our findings reveal specific exosomal miRNA patterns in EOC and ovarian cystadenoma patients, which are indicative of a role of these miRNAs in the pathogenesis of EOC.
机译:特定的microRNA(miRNA)包装在调节肿瘤形成和进展过程的外来体中。当前的研究集中于外泌体miRNA在上皮性卵巢癌(EOC)发病机理中的影响。使用包含48种不同miRNA的基于TaqMan实时PCR的miRNA阵列卡,从106名EOC患者,8名卵巢囊腺瘤患者和29名健康女性的血浆中的外泌体中确定了miRNA谱。在细胞培养实验中,确定了miR-200b和miR-320对卵巢癌细胞系增殖和凋亡的影响。我们报告说miR-21(P = 0.0001),miR-100(P = 0.034),miR-200b(P = 0.008)和miR-320(P = 0.034)显着富集,而miR-16(P = 0.034) 0.009),EOC患者血浆的外泌体中miR‐93(P = 0.014),miR‐126(P = 0.012)和miR‐223(P = 0.029)的含量低于健康女性。卵巢囊腺瘤患者的外泌体miR-23a(P = 0.009,0.008)和miR-92a(P = 009,0.034)的水平分别低于EOC患者和健康女性。 miR-200b的外泌体水平与肿瘤标志物CA125(P = 0.002)和患者总体生存率(P = 0.019)相关。 MiR-200b影响细胞增殖(P = 0.0001)和细胞凋亡(P <0.008)。我们的发现揭示了EOC和卵巢囊状腺瘤患者中特定的外泌体miRNA模式,这表明这些miRNA在EOC发病机理中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号